Whoops,
Here is the full text of PIVOT:
www.nejm.org/doi/full/10.1056/NEJMoa1113162#t=articleDiscussionMy apologies.
There's probably not much more than the following that we can conclude from the PIVOT trial:
> For men with low-risk, early stage, localized prostate cancer who are > 65 years of age and have a life expectancy of not more than 15 years, observation (i.e., active monitoring) is now shown to be every bit as effective as (and a great deal safer than) radical prostatectomy.
> For men with low-risk, early stage, localized prostate cancer who are > 65 years of age and have a life expectancy of more than 15 years, it is arguable that observation (i.e., active monitoring) may be at least as good an option as radical prostatectomy.
Tony
Post Edited (TC-LasVegas) : 12/9/2013 4:32:01 PM (GMT-7)